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Abstract
In this work, our aim was to determine whether L-arginine
(a known insulinotropic amino acid) can promote a shift of
b-cell intermediary metabolism favoring glutathione (GSH)
and glutathione disulfide (GSSG) antioxidant responses,
stimulus–secretion coupling and functional integrity. Clonal
BRIN-BD11 b-cells and mouse islets were cultured for 24 h
at various L-arginine concentrations (0–1.15 mmol/l) in the
absence or presence of a proinflammatory cytokine cocktail
(interleukin 1b, tumour necrosis factor a and interferon g).
Cells were assessed for viability, insulin secretion, GSH,
GSSG, glutamate, nitric oxide (NO), superoxide, urea, lactate
and for the consumption of glucose and glutamine. Protein
levels of NO synthase-2, AMP-activated protein kinase
(AMPK) and the heat shock protein 72 (HSP72) were also
evaluated. We found that L-arginine at 1.15 mmol/l
attenuated the loss of b-cell viability observed in the presence
of proinflammatory cytokines. L-Arginine increased total
cellular GSH and glutamate levels but reduced the
GSSG/GSH ratio and glutamate release. The amino acid
stimulated glucose consumption in the presence of cytokines
while also stimulating AMPK phosphorylation and HSP72
expression. Proinflammatory cytokines reduced, by at least
50%, chronic (24 h) insulin secretion, an effect partially
attenuated by L-arginine. Acute insulin secretion was robustly
stimulated by L-arginine but this effect was abolished in
the presence of cytokines. We conclude that L-arginine can
stimulate b-cell insulin secretion, antioxidant and protective
responses, enabling increased functional integrity of b-cells
and islets in the presence of proinflammatory cytokines.
Glucose consumption and intermediary metabolism were
increased by L-arginine. These results highlight the import-
ance of L-arginine availability for b-cells during inflammatory
challenge.
Journal of Endocrinology (2011) 211, 87–97
Introduction
Obesity, insulin resistance and type 2 diabetes (T2DM) are
known to induce a proinflammatory state that, together with
the adverse effects of hyperglycemia and hyperlipidemia, leads
to the progressive dysfunction and demise of pancreatic
b-cells (Newsholme et al. 2010). Among the factors involved
in the reduction of b-cell viability is the local inflammatory
process in the islets of Langerhans. This is induced by islet
dendritic cell activation and infiltration by T-lymphocytes and
macrophages, leading to microenvironmental changes,
resulting in b-cell injury and death (Masters et al. 2010).
Destruction of b-cells during islet inflammation can be
mediated by direct contact with activated macrophages and by
exposure to soluble mediators secreted by dendritic cells,
macrophages and T-lymphocytes, including cytokines,
oxygen free radicals and nitric oxide (NO; Eizirik &
Mandrup-Poulsen 2001). Indeed, overproduction of NO by
b-cells themselves is one of the most significant mechanisms
leading to b-cell dysfunction and death (Eizirik & Mandrup-
Poulsen 2001). The production of NO is promoted by
inflammatory cytokines which activate the transcription of
b-cell inducible isoform of NO synthase (iNOS, encoded by
the NOS-2 gene), an enzyme whose expression is nuclear
factor kB (NFkB)-driven and which uses L-arginine as
substrate (Eizirik & Mandrup-Poulsen 2001). While excessive
NO production within b-cells may trigger oxidative/
nitrosative stress leading to cell death, NO also serves as an
important b-cell stimulus–secretion coupling factor (Smukler
et al. 2002, Newsholme et al. 2005, 2007a,b, 2010, Krause &
de Bittencourt 2008). L-Arginine is recognized as one of
the most powerful insulin secretagogues (Palmer et al. 1976)
and while it can contribute to promotion of exocytosis
via transport-associated membrane depolarization, there are
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possibly many other mechanisms by which it positively
modulates insulin secretion.At specificconcentrations, evidence
suggests that NO is a physiological regulator of insulin secretion
in b-cells (Spinas 1999, Smukler et al. 2002). The presence of
an NFkB-dependent iNOS while beneficial at low concen-
tration/activity, predisposesb-cells to developmentof oxidative/
nitrosative stress at higher levels, because NO may inhibit meta-
bolism, mitochondrial activity and generation of stimulus–
secretion coupling factors (Krause & de Bittencourt 2008).
Macrophages can release, into the inflammatory islet
microenvironment, the enzyme arginase (Murphy &
Newsholme 1998), which splits L-arginine into urea and
L-ornithine, thus avoiding its conversion into NO and
favoring resolution of inflammation (Zhai et al. 2009).
Interestingly, the depletion of L-arginine itself is sufficient to
inhibit T-cell proliferation by the downregulation of the
z-chain, the main signal transduction component of the
T-cell receptor complex (Bronte & Zanovello 2005). It has
also been demonstrated thatb-cells possess a cytokine-inducible
arginase activity (Stickings et al. 2002), which may account for
reduction in NO synthesis under appropriate conditions.
Although release of arginase by infiltrating macrophages may
promote the resolution of inflammation, restriction of arginine
availability in the islet microenvironment may be detrimental
forb-cell metabolism, antioxidant defenses and insulin secretion
(Newsholme et al. 2010). Interestingly, decreased plasma and
intracellular concentrations of L-arginine have been reported
in patients with type 2 diabetes (Pieper & Dondlinger 1997).
L-Arginine also increased b-cell neogenesis and antioxidant
defenses in rats treated with alloxan and aided recovery of
endothelium-dependent relaxation in patients with type 2
diabetes (Pieper & Dondlinger 1997, Vasilijevic et al. 2007).
Administration of L-arginine has also been reported to reduce
adiposity in obese–diabetic humans, genetic and diet-induced
obese rats as well as finishing pigs (McKnight et al. 2010).
To further investigate the importance of L-arginine for
b-cell function, we determined changes in clonal b-cell
insulin secretion, metabolism, redox status and integrity
in vitro in response to manipulation of L-arginine concen-
tration in tissue culture in the absence or presence of
proinflammatory cytokines. Key experimental findings were
subsequently further explored in heterogeneous (mixed
endocrine cell) mouse islet incubations.
Materials and Methods
Culture of BRIN-BD11 pancreatic b-cells, proinflammatory
cocktail challenge and measurement of insulin secretion at different
L-arginine concentrations
The clonal rat insulin-secreting b-cell line BRIN-BD11 was
chosen because its metabolic, signaling and secretory
responses to glucose, amino acids and other stimuli have
been extensively characterized (McClenaghan et al.
1996, McClenaghan & Flatt 1999, Brennan et al. 2003).
BRIN-BD11 cells were maintained in culture overnight as
described previously (Kiely et al. 2007). After washing with
PBS, cells were incubated in fresh (L-arginine free) RPMI-
1640 medium, supplemented with 11.1 mmol/l D-glucose,
2 mmol/l L-glutamine and different concentrations of
L-arginine (0, 0.1, 0.25 and 1.15 mmol/l).Cellswere incubated
in the presence or absence of a non-lethal (with respect to cells
cultured in normal culture medium) proinflammatory cyto-
kine cocktail (interleukin 1b (IL1b) 0.3125 U/ml, tumour
necrosis factor a (TNFa) 31.25 U/ml and interferon g (IFNg)
15.625 U/ml; Kiely et al. 2007). IL1b has been implicated in
macrophage associated b-cell dysfunction typical of type 2
diabetes (Masters et al. 2010). The L-arginine concentration
range tested was chosen to include absence (0 mM), the
physiological range in human blood (0.1–0.25 mmol/l) and
the normal concentration found in the RPMI-1640 culture
medium (1.15 mmol/l L-arginine). After 24 h, an aliquot of the
medium was removed for insulin assay or centrifuged at
16 000 g for 10 min at 4 8C for the later determination of
metabolites. In addition, for the set of experiments designed to
test the effect of 24 h culture in various concentrations of L-
arginine in the absence or presence of proinflammatory
cytokines on subsequent acutely stimulated insulin secretion,
cells were cultured for 24 h as above, preincubated for 40 min at
1.1 mmol/l glucose and then acutely stimulated for 20 min in
the presence of 16.7 mM glucoseC10 mM alanine. The latter
combination has been shown to evoke a robust and
reproducible insulin secretion response (Brennan et al. 2002,
Kiely et al. 2007). Aliquots of incubation medium were taken
for analysis of insulin using the Mercodia Ultrasensitive Rat
Insulin ELISA kit (Mercodia, Uppsala, Sweden).
Islet isolation and culture; viability and chronic (24 h) insulin
secretion
Pancreatic islets were isolated from wild-type C57 black
mice. Each pancreas was excised and inflated with a Liberase
TL grade solution (Roche 1815032; 8 mg/ml) and chopped
into small pieces. Digestion was initiated during sample
incubation at 37 8C for 3 min with constant shaking.
The digest was washed with 0.1% BSA Krebs solution
(5.6 mM glucose) and the islets were sedimented by gentle
centrifugation (500 g for 10 min at 4 8C) with Histopaque
1077 (Sigma–Aldrich). Islets were resuspended in Krebs buffer
containing 0.1% BSA, individually picked and cultured for
24 h with RPMI-1640 culture medium (as above), in the
presence or absence of a non-lethal proinflammatory cytokine
cocktail (IL1b 0.3125 U/ml, TNFa 31.25 U/ml and IFNg
15.625 U/ml; Kiely et al. 2007) at 0 or 1.15 mmol/l of
L-arginine. Chronic (24 h) insulin release was determined
using the Mercodia Ultrasensitive Mouse Insulin ELISA kit.
Cell viability measurements
The neutral red uptake assay provides a quantitative
estimation of the number of viable cells based on their
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ability to incorporate and bind the dye neutral red in
lysosomes. BRIN-BD11 cells were exposed to different
concentrations of L-arginine, with or without the proin-
flammatory cytokine cocktail as described earlier. After 2 h
incubation in presence of neutral red (100 mg/ml), cells were
washed with PBS followed by disruption with acid ethanol
(alcohol/glacial acetic acid, 50:1v/v). Aliquots of the
resulting solution were transferred to 96-well plates and
absorbance at 540 nm was recorded using a microplate
spectrophotometer (Molecular Devices SpectraMax Plus
384, Sunnyvale, CA, USA). This procedure was highly
reproducible and comparible with other cytotoxicity tests
(tetrazolium salts, enzyme release, or DNA content; Repetto
et al. 2008). To determine cell membrane integrity (an
indirect measurement of cell viability), a lactate dehydrogenase
(LDH) release assay (Biovision, Dublin, Ireland) was used and
the results expressed as percentage of islet LDH released.
There was good correlation between cell membrane
integrity, mitochondrial function and level of apoptosis and
necrosis in a clonal b-cell line exposed to proinflammatory
cytokines (Kiely et al. 2007). Islet b-cells contain a relatively
low content of LDH but this is clearly measurable using the
Biovision kit (Mountain View, CA, USA).
Enzymatic determination of metabolites
Urea and nitrite production, glucose and glutamine con-
sumption and production of glutamate and lactate plus
intracellular glutamate concentration were determined as
described previously (Brennan et al. 2002, Kiely et al. 2007).
Measurement of glutathione and glutathione disulfide content
BRIN-BD11 cells were seeded into six-well plates (1!106
cells/well), allowed to adhere overnight and then washed
with PBS after which they were incubated for 24 h in fresh
media as described earlier. Cells were then rinsed twice
with PBS and disrupted in 200 ml of 5% (w/v) metapho-
sphoric acid on ice. After centrifugation (14 000 g, 5 min at
room temperature), cell lysates were spectrophotometrically
(415 nm) assayed in a temperature-controlled microplate
reader (Molecular Devices SpectraMax Plus 384) by a
modification of the 5,5 0-dithiobis(2-nitrobenzoic acid)
(DTNB)/glutathione disulfide (GSSG) reductase recycling
method, using the N-ethylmaleimide conjugating technique
for GSSG sample preparation (Krause et al. 2007). Samples
(10 ml) were assayed in 105 ml final volume in 96-well
polystyrene plates at 37 8C in the presence of 10 mM DTNB,
0.17 mM b-NADPH (dissolved in 0.5% (w/v) NaHCO3
as a stabilizing agent) and 0.5 U/ml GSSG reductase
(EC 1.6.4.2).
Superoxide production in BRIN-BD11 cells
Dihydroethidium (DHE) is widely used as a probe to measure
superoxide O$2
 
. DHE is cell permeable and reacts with O$2
 
to form ethidium, which in turn intercalates with DNA,
providing nuclear fluorescence at an excitation wavelength of
525 nm and an emission wavelength of 590 nm (Benov et al.
1998). BRIN-BD11 cells were incubated (1!104 cells/
100 ml per well) in a 96-well black plate (Corning, Inc. Costar
3603, Dublin, Ireland) allowed to adhere overnight. Cells
were then washed with PBS and incubated in various
conditions for 24 h as described earlier. Subsequently DHE
was added to the culture medium for 30 min to allow for the
reaction between the dye and the superoxide to reach
completion. The fluorescence was then read (exZ525/emZ
590). The results were expressed as average of fluorescence
intensity/milligram of protein per 24 h.
Preparation of protein extracts from BRIN-BD11 cells
BRIN-BD11 cells were lysed in 150 ml of RIPA lysis
buffer (MSC, Dublin, Ireland) containing protease
inhibitors. Cell lysates were transferred to fresh ice-cold
microcentrifuge tubes and placed on a shaker at 4 8C for
15 min. The cells were then centrifuged at 14 000 g for
15 min at 4 8C. The supernatant fraction was transferred to a
fresh tube and stored at K20 8C. Cellular protein was
determined using a BCA protein assay kit (Pierce, Rockford,
IL, USA; kit no. 23225), which utilizes a modification of the
biuret reaction.
Western blot analysis
Cells were seeded into six-well plates (1.5!106 cells/well),
allowed to adhere overnight and then washed with PBS after
which they were incubated in fresh media for 24 h, in various
conditions as described earlier. Subsequently cells were lysed
and equal amounts of BRIN-BD11 cell protein extracts were
prepared and subjected to 10% SDS–PAGE then electro-
phoretically transferred to a nitrocellulose membrane. The
membranes were blocked in 5% (milk protein or BSA) and
probed with polyclonal antibodies anti-NOS-2 and heat
Table 1 Pancreatic b-cell viability (%, by neutral red assay). Effect of
24 h culture in the presence of various concentrations of L-arginine
on the viability of BRIN-BD11 cells in the absence or presence of
proinflammatory cytokines. Results are presented as percentage of




1.15 mM L-arginine 100G8.7†,‡ 96.3G8.1†,‡,§
0.25 mM L-arginine 94G3*,† 56.3G10.9†,s
0.1 mM L-arginine 89G4.6*,† 56.1G20.9†,s
No L-arginine 61G4.6* 42.1G4.5
*P!0.05 versus cytokine treatment at the same L-arginine concentration;
†P!0.05 vs 0 mmol/l L-arginine; ‡P!0.05 vs 0.1 mmol/l L-arginine;
§P!0.05 vs 0.25 mmol/l L-arginine; and sP!0.05 vs 1.15 mmol/l L-arginine.
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shock protein 72 (HSP72; Sigma–Aldrich); anti-AMP-
activated protein kinase (AMPK), phosphorylated AMPK
(AMPK-P; Cell Signalling Technologies, Denvers, MA, USA).
The blots were washed and visualized with a HRP-based
Supersignal West Pico chemiluminescent substrate (Pierce).
Results of digitalized images were expressed as meansGS.D.
using anti-GAPDH antibodies for GAPDH detection (Cell
Signalling Technologies) as an expression control.
Statistical analysis
Following confirmation of a normal distribution through the
use of repeated Shapiro–Wilks tests, paired and unpaired two-
tailed Student’s t-tests were used where appropriate to
evaluate the statistical significance of differences between
the group means and ANOVA was used for multiple
comparisons. Data are presented as meansGS.D. and
differences were considered significant at a P value of !0.05.
Results
Effect of L-arginine on BRIN-BD11 cell viability in the absence
or presence of a proinflammatory cytokine cocktail
The effects of 24 h culture in the presence of various
concentrations of L-arginine on the viability of BRIN-BD11
cells in the absence or presence of proinflammatory cytokines
was investigated using the neutral red assay. Consistent with
the importance of L-arginine for the maintenance of b-cell
function, viability of BRIN-BD11 cells decreased from a
normalized value of 100–61% in the absence of the amino
acid (Table 1). Loss of viability was more dramatic when the
proinflammatory cytokine cocktail was added, reducing
viability to 40% of control in the absence of L-arginine.
While ‘viability’ measurements invariably determine loss of
cell function, e.g. loss of plasma membrane integrity by LDH
release, or reduced lysosomal function via binding of neutral
red, or activation of enzymes associated with cell apoptosis,
key cell structures may remain intact at the time of assay.
Thus, BRIN-BD11 cells were still able to metabolize
glutamine at high rates and maintain their GSSG/glutathione
(GSH) ratio, even when neutral red binding capacity was
severely reduced (see below).
Effect of L-arginine on GSH levels, intracellular glutamate levels,
glutamate release and glutamine consumption in BRIN-BD11
cells in the absence or presence of a proinflammatory cytokine
cocktail
The effects of 24 h culture in the presence of various
concentrations of L-arginine on GSH levels, cellular redox
state, glutamate levels, glutamate release and glutamine
consumption of BRIN-BD11 cells in the absence or presence
of proinflammatory cytokines was investigated. Since gluta-
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is important precursors for b-cell GSH synthesis (Brennan
et al. 2003), both reduced and oxidized forms of GSH were
determined as was the GSSG/GSH ratio in addition to
intracellular glutamate levels, glutamate release plus glutamine
consumption. The intracellular levels of reduced GSH
increased substantially in the presence of L-arginine (Table 2)
from 0.13G0.01 mmol/mg (0 mmol/l L-arginine) to 0.92
G0.14 mmol/mg (1.15 mmol/l L-arginine). This greater than
sixfold increase evoked by L-arginine was concentration-
dependent (Table 2). Levels of GSH disulfide were also
increased but to a much lesser extent. Intracellular glutamate
did not change when cells were exposed to physiologic or
high concentrations of L-arginine (Table 3). However, in
the total absence of L-arginine, intracellular glutamate
concentration was decreased by w50% indicating that a
minimum concentration of L-arginine was essential for the
maintenance of b-cell glutamate levels (Table 3). Glutamate
release was increased approximately fourfold by cytokine
exposure, but amounts of glutamate released were lowered
when the L-arginine concentration was increased. With
respect to glutamine consumption, an approximate fourfold
increase (from 3.52G0.87 to 15.05G3.05 mmol/mg)
was observed with all cytokine incubations. This was unchan-
ged by manipulation of L-arginine concentration (Table 3).
Effect of L-arginine on chronic (24 h) or acute (20 min)
insulin secretion, glucose consumption and lactate production
by BRIN-BD11 cells in the absence or presence of a
proinflammatory cytokine cocktail
The effects of 24 h culture in the presence of various
concentrations of L-arginine on insulin secretion, glucose
consumption and lactate production from BRIN-BD11 cells
in the absence or presence of proinflammatory cytokines was
investigated. As expected, L-arginine stimulated chronic
(24 h) tissue culture insulin release (by 28%) from cells
cultured at 1.15 mM compared with 0 mM L-arginine
(928 mg/mg protein compared with 727 mg/mg protein,
Fig. 1A). In the presence of proinflammatory cytokines,
insulin secretion was blunted by at least 50% in all incubations
(Fig. 1A). Glucose consumption and lactate production were
augmented by proinflammatory cytokine challenge (Table 3).
Interestingly, glucose consumption and lactate production
were further increased at higher L-arginine concentrations. It
is also important to note that L-arginine increased glucose
consumption and lactate production in the absence of
cytokines, indicating L-arginine is able to alter b-cell
glycolytic metabolism to pyruvate, so promoting lactate
production and pyruvate oxidation. In a separate experiment
BRIN-BD11 cells were cultured for 24 h in various
concentrations of L-arginine in the absence or presence of
proinflammatory cytokines and then subsequently stimulated
for 20 min with a potent insulinotropic nutrient mixture
(glucoseCalanine, Fig. 1B–E). Cells cultured for 24 h in the
absence of L-arginine were associated with reduced GSH
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glutamate (a key stimulus secretion coupling factor) as
described earlier, which contribute to attenuation of
acute glucoseCalanine stimulated insulin secretion
(Fig. 1E). This increase of glucose metabolism in cells
incubated in the absence of cytokines was associated with
enhanced insulin release from cells acutely stimulated with
glucoseCalanine (Fig. 1B–D). However, addition of cytokine
cocktail potently attenuated nutrient-stimulated insulin
secretion, an effect that has been previously reported (Kiely
et al. 2007).
Effect of L-arginine on NOS-2 expression, production of nitrite,
urea and superoxide by BRIN-BD11 cells in the absence or
presence of a proinflammatory cytokine cocktail
The effects of 24 h culture in the presence of various
concentrations of L-arginine on NOS-2 expression, nitrite,
urea production and superoxide generation in BRIN-BD11
cells in the absence or presence of proinflammatory cytokines
was investigated. Since proinflammatory cytokines are likely
to induce oxidative stress by the generation of oxygen- and
nitrogen-based free radicals, iNOS expression, NO and
superoxide production were examined. Cytokine addition
resulted in a large increase in iNOS protein levels (Fig. 2).
This increment was dependent on extracellular L-arginine and
showed clear concentration-dependency. iNOS was not
detectable in the absence of the cytokine cocktail. As a
consequence greater amounts of NO were detected (by the
production of nitrite) in proportion to the extracellular
L-arginine concentration (Fig. 2C). Urea levels were
determined in the absence or presence of cytokines at all
L-arginine concentrations (Fig. 2D), but while cytokines
increased urea production this was not altered by L-arginine
concentration. L-arginine availability (with the exception of
zero concentration) was inversely proportional to superoxide
production (Fig. 2E) perhaps as a result of the effect of the
lack of L-arginine availability on the uncoupled iNOS
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Figure 1 Effect of 24 h culture in the presence of various
concentrations of L-arginine in the absence or presence of
proinflammatory cytokines on chronic insulin secretion and
subsequent 20 min acute nutrient stimulation of insulin secretion
by BRIN-BD11 cells. (A) Chronic insulin secretion. 24 h pre-
incubation in 1.15 mmol/l L-arginine (B); 24 h preincubation in
0.25 mmol/l L-arginine (C); 24 h preincubation in 0.10 mmol/l
L-arginine (D); and 24 h preincubation in 0 mmol/l L-arginine (E).
Cytokines were added to the 24 h culture where indicated.
Data are meansGS.D. of three separate preparations. Significance:
*P!0.05 versus cytokine treatment at the same L-arginine
concentration; DP!0.05 vs 0 mmol/l L-arginine; ¥P!0.05 versus
respective basal; ‡P!0.05 vs 0.1 mmol/l L-arginine; †P!0.05 vs
0.25 mmol/l L-arginine; and jP!0.05 vs 1.15 mmol/l L-arginine.
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Figure 2 Effect of 24 h culture in the presence of various
concentrations of L-arginine on NOS-2 expression, nitrite, urea
production and superoxide generation in BRIN-BD11 cells in the
absence or presence of proinflammatory cytokines. NOS-2
expression (A and B) is shown relative to GAPDH as control. Parts
of the same representative gel are mounted and shown for each
immunoblot. Results are shown for (C) NO production evaluated by
measuring nitrite, (D) urea production and (E) superoxide
production. Data are meansGS.D. of three separate preparations.
Significance: *P!0.05 versus cytokine treatment at the same
L-arginine concentration; DP!0.05 vs 0 mmol/l L-arginine;
‡P!0.05 vs 0.1 mmol/l L-arginine; †P!0.05 vs 0.25 mmol/l
L-arginine; and jP!0.05 vs 1.15 mmol/l L-arginine.
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Effect of L-arginine on the phosphorylation state and protein levels
of AMPK and protein levels of HSP72 in the absence or presence
of a proinflammatory cytokine cocktail
Since b-cell metabolism is dependent on regulation by
the activity of key enzymes such as AMPK (Kiely et al.
2007, Newsholme et al. 2007b), protein levels of AMPK
and its AMP-P were determined following 24 h incubation
in various concentrations of L-arginine in the absence or
presence of proinflammatory cytokines. L-Arginine evoked
concentration-dependent activation of AMPK (as deter-
mined by phosphorylation status) that was further enhanced
by the addition of the cytokine cocktail, at the higher
concentrations of the amino acid (Fig. 3). HSP72, a protein
involved in stress adaptation in all cell types (Krause &
Rodrigues-Krause 2011), was also investigated. L-Arginine
increased HSP72 levels in a dose-dependent manner but, with
the exception of the 1.15 mM L-arginine condition, cytokine
exposure did not significantly change HSP72 content (Fig. 3).
Effect of L-arginine on LDH release and chronic (24 h) insulin
secretion from mouse islets in the absence or presence of a
proinflammatory cytokine cocktail
To confirm validity of observations using BRIN-BD11 cells
reported above, experiments were made using mouse islets as
primary cell model. The effect of 24 h culture in the presence
of either 0 or 1.15 mmol/l L-arginine on cell viability and
chronic insulin secretion of mouse islets after 24 h incubation
in the absence or presence of proinflammatory cytokines
were investigated. Islets incubated in media lacking L-arginine
were associated with a significant increase in LDH release
compared with islets incubated in the presence of 1.15 mM
L-arginine (Fig. 4A). This finding, together with the results
on islet function (chronic insulin secretion) confirmed that
L-arginine is essential for viability of primary islet cells as well
as clonal b-cells. Chronic (24 h) insulin release from cultured
islets was also significantly attenuated (by w70%) in the
absence of L-arginine, an effect that was also evident in the
presence of inhibitory cytokine cocktail irrespective of
the absence or presence of L-arginine (Fig. 4B).
Discussion
L-Arginine is synthesized from glutamine, glutamate and
proline via the intestinal-renal axis in humans and most other
mammals (Wu et al. 2009). It is essential for metabolism and
function of multiple body organs, with decreased plasma and
cellular levels reported in type 2 diabetic subjects (Pieper &
Dondlinger 1997). Since the amino acid is the precursor of
NO that serves as a key cell signaling molecule, restriction
in the availability of L-arginine is likely to contribute
to derangements in the secretion and action of insulin
(Newsholme et al. 2010).
While excessive NO production can trigger oxidative/
nitrosative stress and is undoubtedly a key contributor to
b-cell death (Palmer et al. 1976, Newsholme et al. 2005,
2007a,b, 2010, Michalska et al. 2010), evidence now suggests
that lesser amounts of NO, produced by the NFkB-regulated
iNOS, serve as an important coupling factor in insulin-
secreting cells (Palmer et al. 1976, Newsholme et al. 2005,
2007a,b, 2010, Michalska et al. 2010). We have demonstrated
herein that L-arginine is an important stimulator of b-cell
glucose consumption and intermediary metabolism. Such
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Figure 3 Effect of 24 h culture in the presence of various
concentrations of L-arginine on the expression of AMPK and its
AMPK-P and also the levels of HSP72 in BRIN-BD11 cells in the
absence or presence of proinflammatory cytokines. Results are
expressed as meanGS.D. of at least three separate preparations in
duplicate using GAPDH as an expression control. Parts of the same
representative gel are mounted and shown for each immunoblot.
Data are meansGS.D. Significance: *P!0.05 versus cytokine
treatment at the same L-arginine concentration; DP!0.05 vs
0 mmol/l L-arginine; ‡P!0.05 vs 0.1 mmol/l L-arginine; †P!0.05 vs
0.25 mmol/l L-arginine; and jP!0.05 vs 1.15 mmol/l L-arginine.
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Figure 4 Effect of 24 h culture in the presence of either 0 or 1.15 mM
L-arginine onmembrane integrity as assessed by LDH release (A) and
chronic (24 h) insulin secretion (B) of mouse islets in the absence or
presence of proinflammatory cytokines. Cellular LDH release results
are presented as percentage of cellular LDH released over 24 h of
incubation according to the manufacturer’s instructions (Biovision,
Dublin, Ireland) following incubation in the presence of either 0 or
1.15 mmol/l. Insulin secretion results are expressed as nanograms
insulin released/islet for insulin secretion. Results are expressed as
meanGS.D. of three separate preparations. Significance: *P!0.05
for control versus cytokine treatment at the same L-arginine
concentration and DP!0.05 vs 1.15 mmol/l L-arginine.
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actions lead to increased insulin secretion, enhanced
antioxidant and protective responses with greater functional
integrity when challenged with proinflammatory cytokines.
Given that insulin-secreting cells have very low expression
levels of antioxidant enzymes such as catalase and GSH
peroxidase (Lenzen et al. 1996, Tiedge et al. 1997), b-cells are
particularly prone to chemical stress in the diabetogenic or
inflammatory environment typical of type 1 and possibly type
2 diabetes (Rocie et al. 1997, Santini et al. 1997, Kiely et al.
2007, Newsholme et al. 2007a, Michalska et al. 2010). The
novel finding that L-arginine increased glucose consumption
and lactate production in pancreatic b-cells, both in the
presence or absence of cytokines, indicates that L-arginine is
able to promote b-cell glycolytic flux in a concentration-
dependent manner. Because glycolysis is essential to produce
ATP (for stimulus–secretion coupling) and other energy-
dependent process such as protein and GSH synthesis, this
cellular response may be essential during inflammation of the
pancreatic islet. The molecular mechanisms of the effect of
L-arginine on glycolysis remains unknown but may be
mediated via interaction at key regulatory points such as
GLUT2, glucokinase, or phosphofructokinase 1. As T2DM
patients are associated with lower levels of plasma L-arginine
then the reduced availability of this amino acid could, at least
in part, explain the reduced insulin secretory response during
metabolic challenge in vivo (Salehi et al. 2010).
These positive actions of L-arginine on viability, antiox-
idant status and insulin secretion are likely to reflect, in large
part, the importance of GSH and the GSH reductase/per-
oxidase systems as the main line of antioxidant defense in
b-cells. To maintain GSH, b-cells may either regenerate it
from GSSG via a GSSG reductase catalyzed reaction or
synthesize it, de novo, through the concerted action of g
glutamylcysteine synthetase and GSH synthetase, which are
ATP-consuming enzymes (see Fig. 5 for metabolic scheme).
Regeneration of GSH from GSSG, which utilizes NADPH as
a cofactor but does not require ATP, is metabolically less
expensive than the de novo synthesis from the constituent
amino acids. However, pentose phosphate shunt activity is
relatively low in b-cells (Droge 2002), which is exacerbated
by the high flux of glucose directed toward ATP production
(Krause & de Bittencourt 2008). Therefore, b-cell NADPH
can be obtained from the cytosolic malic enzyme, capable of
converting malate to pyruvate with the concomitant
production of NADPH from NADPC (MacDonald 1995).
De novo GSH synthesis, on the other hand, is completely
dependent on the supply of glutamate, not only because this
amino acid is a constituent of the GSH molecule, but is also an
amino acid donor in the synthesis of serine, which
subsequently can be converted to glycine, via a reaction
requiring tetrahydrofolate. In fact, previous reports from
our laboratories have highlighted the importance of
glutamine and alanine (which give rise to glutamate) for
GSH generation, insulin secretion and protection against
proinflammatory cytokines (Brennan et al. 2002, 2003,
Cunningham et al. 2005).
The observation reported herein, that L-arginine is able to
increase b-cell GSH synthesis, regardless of the presence or
absence of proinflammatory cytokines, sheds light on an as yet
unappreciated facet of b-cell metabolism, namely that
L-arginine could be a precursor of GSH via glutamate
generation (as L-arginine enhanced glutamate production and
decreased glutamate release). This scenario is illustrated in a
metabolic scheme depicted in Fig. 5. Increasing L-arginine
availability allows for an increase in metabolic flux that
produces glutamate from L-arginine by coupling production
of L-ornithine to L-glutamate formation via pyrroline-5-
carboxylate dehydrogenase and ornithine aminotransferase as
described previously (Malaisse et al. 1989). This latter pathway
may be important when L-glutamine or L-alanine availability
is compromised. Inclusion of 0.25 mmol/l L-arginine in
culture was sufficient to provide redox protection, as
estimated by GSSG–GSH ratio. This suggests that L-arginine
is an essential source of L-glutamate for GSH synthesis and
maintenance of redox state during periods of inflammatory
stress. Superoxide production evoked by proinflammatory
cytokines was significantly reduced at higher L-arginine
levels (Fig. 5).
The activation of the iHSP70 is sine qua non for the
promotion of tissue repair, since the expression of this
chaperone confers cytoprotection and also exerts anti-
inflammatory effects (Krause & Rodrigues-Krause 2011).
The increase in the levels of HSP72 induced by L-arginine in
b-cells could be one of the key mechanisms mediating the
observed protection against stress and inflammation. Thus,
the higher level of HSP72 together with the increment in
GSH synthesis induced by L-arginine may provide effective
b-cell protection against inflammatory insult.
The stimulation of insulin release by L-arginine involves
transport of the cationic amino acid into b-cells (via the
amino acid transporter mCAT2A). This leads to direct
membrane depolarization, activation of voltage-dependent
Ca2C channels, Ca2C influx, elevation of intracellular Ca2C
and discharge of insulin by exocytosis (Newsholme et al.
2005). The finding that L-arginine significantly increased
b-cell glucose consumption is a novel finding and suggests
that L-arginine promotes diversion of glucose carbon from
mitochondrial oxidation toward the formation of NADPH
via the cytosolic malic enzyme, so requiring that glucose-
derived-malate is transported from the mitochondrial matrix
to the cytosol. Indeed, we believe that, in the presence of
L-arginine, glutamate can be generated from both L-arginine
and glucose (via 2-oxoglutarate formation and transamination
of glutamate) and is subsequently utilized for GSH synthesis
(Fig. 5). However, in an early study, oxidation of L-arginine
was barely detectable in the presence or absence of glucose,
with the authors concluding that the amino acid does
not give rise to oxidative intermediates (Hellman et al.
1971). This is entirely in agreement with our findings, as
L-arginine conversion to glutamate and GSH does not
require oxidation of L-arginine carbon, thus does not directly
result in stimulation of ATP synthesis. However, the
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L-arginine-dependent stimulation of glucose consumption
may lead to elevated ATP levels. Thus, the long-accepted
view that L-arginine exerts a stimulatory effect on insulin
secretion in the presence of glucose, simply due to
membrane depolarization induced by transport of a
positively charged amino acid across the membrane must
be revised. We propose that L-arginine exerts its positive
effects via a combination of membrane depolarization, its
metabolism to NO (and citrulline) or ornithine (and urea)
and subsequent conversion to glutamate and GSH as well as
an enhancement of glucose metabolism, so contributing
to both stimulus–secretion coupling and antioxidant status.
The fact that proinflammatory cytokines can impair insulin
secretion even in the presence of high concentrations of
L-arginine may indicate that non-lethal concentrations of
proinflammatory cytokines shift b-cell metabolism away
from energy generation and stimulus–secretion coupling
and toward a catabolic state which may be related to cell
defense (Kiely et al. 2007), as indicated by the GSH
metabolism changes reported here.
The significance of AMPK in b-cell stimulus–secretion
coupling is as yet unclear (Newsholme et al. 2007b), but
L-arginine enhanced the level of AMPK-P in BRIN-BD11


























































































Figure 5 Scheme depicting major pathways relating to L-arginine metabolism in pancreatic b-cells. Entry of L-arginine into b-cells occurs via
cationic transporters (CAT) in the plasma membrane and can be enhanced by cytokines. Once inside the cell L-arginine can be metabolized
by iNOS to produce nitric oxide and citrulline and/or by arginase producing ornithine and urea. Ornithine can be converted subsequently
in a sequence of reactions to pyrroline-5-carboxylate (P5C), glutamate semialdehyde and finally to glutamate. The glutamate produced is
used for the synthesis of glutathione to enhance cell protection. Under normal secretagogue-induced insulin release, both NO and GSH
are obligatory intermediates. Accordingly, b-cells have an intricate iNOS-centered machinery to produce NO, which potentiates insulin
secretion physiologically. At the same time, b-cells utilize glutamate-derived GSH to maintain redox status needed to allow secretion and to
avoid a possible NO-mediated cytotoxicity. L-Arginine is an established insulin secretagogue that depolarizes the cell membrane by virtue of
its positive charge, leading to influx and elevation of intracellular Ca2C. On the other hand, L-arginine increases b-cell metabolism leading to
increments in glucose consumption, NADPH and lactate. Lack of L-arginine will result in decreased metabolism and reduced glutathione
production, leading to a fragile state against stress factors such as inflammation and free radicals. Low L-arginine availability would also
result in decreased ATP production, blunting the insulin secretion. Enzymes/reactions: 1, iNOS (inducible nitric oxide synthase); 2, arginase;
3, ornithine aminotransferase; 4, pyrroline-5-carboxylate dehydrogenase; 5, aspartate-aminotransferase (a: mitochondrial and b: cytosolic);
6, a-ketoglutarate dehydrogenase; 7, succinate thiokinase; 8, succinate dehydrogenase; 9, fumarase; 10a, malate dehydrogenase;
10b, cytosolic malate dehydrogenase; 11, citrate synthase; 12, aconitase; 13, isocitrate dehydrogenase; 14, argininosuccinate synthase;
15, argininosuccinate lyase; 16, g-glutamylcysteine synthetase; 17, glutathione synthetase; 18, glutathione peroxidase; 19, glutathione
reductase; 20, malic enzyme; 21, lactate dehydrogenase; 22, glucokinase; 23, pentose phosphate pathway; 24, pyruvate carboxylase;
25, pyruvate dehydrogenase; 26, GLUT2; 27, glutaminase.
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L-arginine supplementation in Zucker diabetic fatty rats,
resulted in powerful activation of HO-3, AMPK and
PGC-1a (PPARg coactivator 1a), which would be expected
to increase mitochondrial biogenesis and increase oxidative
metabolism in skeletal and cardiac muscle, brain, liver and
adipose tissue (Fu et al. 2005). It has been suggested that
changes in AMPK activity may also contribute to b-cell
functional integrity (Wang et al. 2007, Nyblom et al. 2008).
Thus, activation of AMPK by L-arginine may not only
promote fatty acid oxidative metabolism thereby driving
ATP production, but it may also serve to counter b-cell
glucolipotoxicity.
In summary, L-arginine exerts a broad spectrum of
beneficial effects on clonal b-cells and isolated islets in
addition to simple membrane depolarization and triggering of
insulin secretion. The novel findings reported in this paper
suggest an important role of L-arginine in promotion of GSH
synthesis and antioxidant defense that may encourage the
development of novel strategies for the protection of b-cells
against chemical/immune insult and diabetes.
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